Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Ophthalmology | Family Medicine
Diabetic Retinopathy Clinical Trials
A listing of Diabetic Retinopathy medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Mesa : Barnet Dulaney Perkins Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Phoenix : Barnet Dulaney Perkins Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
California
Los Angeles : Jules Stein Eye Institute, Dept. of Ophthalmology, David Geffen School of Medicine at UCLA
Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
Torrance : Retina Macula Institute
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Florida
Clearwater : Retina Vitreous Associates of Florida
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Fort Lauderdale : Retina Group of Florida
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
St. Petersburg : Retina Vitreous Associates of Florida
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Iowa
Cedar Rapids : Iowa Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Iowa City : University of Iowa Department of Ophthalmology and Visual Sciences
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Kansas
Shawnee Mission : Retina Associates, PA
Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Maryland
Baltimore : Johns Hopkins Unversity
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Massachusetts
Boston : Ophthalmic Consultants of Boston
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
Rockland : Call EMD Serono Medical Information for information on recruiting sites
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
New York
Lynbrook : Ophthalmic Consultants of Long Island
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Pennsylvania
Pittsburgh : Neuro Kinetics Inc.
Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
Texas
Dallas : UT Southwestern Medical Center
Diabetic Retinopathy And the Myvisiontrack™ App (DRAMA) Study
Houston : Robert Cizik Eye Clinic - University of Texas Houston
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Houston : Retina Consultants of Houston
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
McAllen : Valley Retina Institute
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Washington
Tacoma : Chous Eye Care Associates
Diabetes Visual Function Supplement Study
Denmark
Odense : Syddansk Universitet (SDU)
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
France
Paris : AP - Hopitaux de Paris (AP-HP)
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Germany
Aachen : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Chemnitz : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Darmstadt : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Duesseldorf : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Essen : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
View More »
Frankfurt : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Freiburg i. Br : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Hamburg : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Kiel : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Koeln : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Leipzig : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Marburg : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Muenster : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
München : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Recklinghausen : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Regensburg : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Siegburg : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Tübingen : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Ulm : Novartis Investigative Site
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Ulm : Universitaet Ulm (UUlm)
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
India
Kochi : Amrita
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Vizag : LVPEI
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Mexico
Mexico City : Conde De Valenciana
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Monterrey : Hidalgo
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
San Lucas : La Ceguera
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Portugal
Coimbra : Aibili - Cec
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Spain
Barcelona : Institut Catala de la Salut - Hospital Universitari Vall d'Hebron (ICS-HUVH)
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Switzerland
Zurich : Department of Ophthalmology, Triemli Hospital Zurich
A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)
United Kingdom
Ayr : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Belfast : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Birmingham : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Birmingham : Aston University (UAston)Heart of England NHS Foundation Trust
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Cardiff, : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
View More »
Cheltenham : Gloucestershire Hospitals NHS Foundation Trust (CHGH)
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Colchester : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Fife : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Hull : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Liverpool : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
London : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
London : Moorfields Eye Hospital NHS Foundation Trust (MEH)
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Rugby : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
York : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
